Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial
Go back to Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 2.31 +0.05 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.26 | 52 Week High | $9.58 | |||
| Open | $2.22 | 52 Week Low | $2.34 | |||
| Day High | $2.34 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $-0.34 | |||
| Volume | 115,603 | |||||
